Last reviewed · How we verify
Sulfazol (sulfamethylthiazole)
Sulfazol (generic name: sulfamethylthiazole) is a sulfamethylthiazole drug. It is currently in unknown development.
Sulfazol works by inhibiting the growth of bacteria by interfering with their ability to synthesize folic acid.
Sulfazol, also known as sulfamethylthiazole, is a small molecule drug in the sulfamethylthiazole class. Unfortunately, there is limited information available on its target, mechanism of action, and clinical use. As a result, it is difficult to provide a comprehensive summary of its therapeutic applications and safety profile. Further research is needed to determine its commercial status and potential indications. Currently, there is no information available on its half-life, bioavailability, or generic manufacturers.
At a glance
| Generic name | sulfamethylthiazole |
|---|---|
| Drug class | sulfamethylthiazole |
| Therapeutic area | Infectious Disease |
| Phase | unknown |
Mechanism of action
Think of it like a puzzle: bacteria need a certain piece to build a crucial part of themselves. Sulfazol blocks that piece from being made, so the bacteria can't grow and multiply. This helps to treat infections caused by these bacteria.
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Sulfazol CI brief — competitive landscape report
- Sulfazol updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Sulfazol
What is Sulfazol?
How does Sulfazol work?
What is the generic name of Sulfazol?
What drug class is Sulfazol in?
What development phase is Sulfazol in?
Related
- Drug class: All sulfamethylthiazole drugs
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Infectious Disease
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing